Louisiana's New Abortion Drug Law Sparks Controversy

Louisiana Governor Jeff Landry has signed groundbreaking legislation classifying two abortion-inducing drugs, mifepristone and misoprostol, as controlled substances. While supporters claim it protects against coerced abortions, many physicians argue the law could hinder vital reproductive healthcare. This debate highlights the ongoing conflicts over abortion regulations.

First-of-its-kind legislation that classifies two abortion-inducing drugs as controlled and dangerous substances has been signed into law by Louisiana Gov. Jeff Landry.

The Republican governor announced his signing of the bill in Baton Rouge on Friday, a day after it gained final legislative passage in the state Senate. Opponents of the measure included many physicians who said the drugs have other critical reproductive healthcare uses, and that changing the classification could make it harder to prescribe the drugs. Supporters of the bill, which affects the drugs mifepristone and misoprostol, said it would protect expectant mothers from coerced abortions, though they cited only one example of that happening, in the state of Texas.